[1] |
王锡山.中美结直肠癌流行病学特征对比及防控策略分析[J].中华结直肠疾病电子杂志,2019,8(1):1-5.
|
[2] |
刘自帅,金世柱,杨宁宁,等.影响结肠镜检查的基础质量控制因素[J].胃肠病学和肝病学杂志,2019,28(9):1038-1041.
|
[3] |
Kim SY,Kim HS,Park HJ.Adverse events related to colonoscopy:Global trends and future challenges[J].World J Gastroenterol,2019,25(2):190-204.
|
[4] |
邢曼,史士强,高静,等.复方聚乙二醇电解质散(Ⅳ)引起电解质紊乱、代谢性酸中毒和低钠血症性脑病[J].药物不良反应杂志,2020,22(4):270-271.
|
[5] |
班炳坤,韦敬土,王明扬,等.直肠癌患者使用复方聚乙二醇电解质散进行肠道清洁死亡1例分析[J].中国医院药学杂志,2020,40(5):591-592.
|
[6] |
Rey E,Mearin F,Alcedo J,et al.Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome:An Expert Consensus Report[J].Adv Ther,2017,34(3):587-598.
|
[7] |
Bassotti G,Usai-Satta P,Bellini M.Linaclotide for the treatment of chronic constipation[J].Expert Opin Pharmacother,2018,19(11):1261-1266.
|
[8] |
Love BL,Johnson A,Smith LS.Linaclotide:a novel agent for chronic constipation and irritable bowel syndrome[J].Am J Health Syst Pharm,2014,71(13):1081-1091.
|
[9] |
高燕,张厚德,林木贤,等.Boston 肠道准备量表应用的信度评估[J].中华消化内镜杂志,2012,29(2):78-80.
|
[10] |
都贤,时晓冬,牛巍巍,等.2019 欧洲胃肠道内镜学会结肠镜检查肠道准备指南解读[J].河北医科大学学报,2020,41(4):373-376.
|
[11] |
李潘,李月月,李延青.个体化肠道准备对肠道准备质量的 影响[J].山 东 大 学 学 报(医 学版),2020,58(3):113-117.
|
[12] |
孟小芬,张迪,杨屹,等.复方聚乙二醇电解质散联合硫酸镁给药方法对便秘患者肠道准备的研究[J].中国内镜杂志,2018,24(4):38-41.
|
[13] |
中国医师协会内镜医师分会消化内镜专业委员会,中国抗癌协会肿瘤内镜学专业委员会.中国消化内镜诊疗相关肠道准备指南(2019,上海)[J].中华内科杂志,2019,58(7):485-495.
|
[14] |
廖锦文,龙文秀,吴兰,等.复方聚乙二醇电解质散不同给药方式对便秘患者肠道准备清洁效果的影响[J].中国现代医生,2020,58(12):94-97.
|
[15] |
盛珺,姜莉,安然.结肠镜检查前复方聚乙二醇电解质散在不同时间段的应用对肠道清洁以及患者睡眠质量的影响[J].当代护士(上旬刊),2019,26(9):128-130.
|
[16] |
Ahsan MK,Tchernychev B,Kessler MM,et al.Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-Ⅱ-dependent trafficking of CFTR in the intestine[J].Physiol Rep,2017,5(11):e13299.
|
[17] |
McHugh DR,Cotton CU,Moss FJ,et al.Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3[J].Am J Physiol Gastrointest Liver Physiol,2018,315(5):G868-G878.
|
[18] |
Fukudo S,Miwa H,Nakajima A,et al.High-dose linaclotide is effective and safe in patients with chronic constipation:A phase Ⅲrandomized,double-blind,placebo-controlled study with a long-term open-label extension study in Japan[J].Neurogastroenterol Motil,2019,31(1):e13487.
|